Generic Fulvestrant Injection Launched for Breast Cancer Monotherapy in Post-Menopausal Women
October 1st 2019Fulvestrant injection treats certain types of breast cancer in post-menopausal women who were not previously treated with endocrine therapy and as a combination for advanced or metastatic breast cancer.
Read More
Canagliflozin Approved by FDA for Diabetes-Related Kidney Disease
September 30th 2019Officials from the FDA have approved the Janssen Pharmaceutical Companies of Johnson & Johnson’s canagliflozin (Invokana) to reduce the risk of end-stage kidney disease (ESKD) and cardiovascular events in patients with Type 2 Diabetes and chronic kidney disease (CKD).
Read More
Finding Modern Medicines in Ancient Cultures
September 29th 2019Along with her B.S. in pharmacy from UNC-Chapel Hill, author Amy Greeson’s education has included some much more unique experiences. She’s been to Belize to study native therapies, studied in the Amazon with a local medicine man and woman, and learned from traditional healers in Mexico.
Read More
FDA Approves Injection for Children with GPA, MPA
September 28th 2019The FDA has given the green light to rituximab (Rituxan) injection for the treatment of granulomatosis with polyangiitus (GPA) and microscopic polyangiitis (MPA) in children age 2 and older in combination with glucocorticoids. The application was approved under priority review and with orphan designation.
Read More
Results from New Trial Show Vitamin D and Fish Oil Hopeful in Prevention of Cancer and CVD
September 25th 2019The vitamin D and omega-3 clinical trial (VITAL) is the largest, most recent study to test this subject matter, with nearly 26,000 United States men and women participating in the trial.
Read More